Becton Dickinson announces 4.6% dividend increase in 2022
On november 10, 2022, Becton Dickinson and Company (trading symbol BDX) declared a quarterly dividend of $0.91 per share, up 4.6% from the previous quarterly dividend. This will mark the 51st consecutive year of increased dividends by the Dividend Aristocrat.
The next BDX dividend will be payable on Dec. 30, 2022 to holders of record on Dec. 9, 2022. The indicated annual dividend rate for fiscal year 2023 is $3.64 per share. This translates into an estimated dividend yield of 1.6% for Becton Dickinson at a stock price of $224.
BECTON DICKINSON ANNUAL DIVIDEND GROWTH
- 2022: +4.6%
- 2021: +4.8%
- 2020: +5.1%
- 2019: +2.6%
- 2018: +2.7%
"This is the 51st consecutive fiscal year in which we have raised our dividend, maintaining BD's membership in the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends for at least 25 consecutive years," said Tom Polen, chairman, CEO and president of BD. "This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value through execution of our BD 2025 strategy and return capital to shareholders."
Other Dividend Aristocrats announcing dividend hikes in november are insurer Aflac (30 consecutive years of growth) and technology company Roper (40 straight years of dividend growth). Last year Becton Dickinson hiked its dividend by 4.8%, marking the 50th straight year of dividend growth.
Becton Dickinson is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Becton Dickinson operates through segments including BD Medical, BD Life Sciences and BD Interventional. The company has raised its dividend for 50 consecutive years and is one of the S&P 500 Dividend Aristocrats.